By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aureon Laboratories 

28 Wells Avenue

Yonkers  New York  10701  U.S.A.
Phone: 914-377-4000 Fax: 914-377-4001



Company News
Aureon Laboratories Named 2010 Recipient of Yonkers Hidden Treasure Award 5/5/2010 8:27:42 AM
Aureon Laboratories Raises $18 Million 3/19/2010 7:31:43 AM
Aureon Laboratories Announces Name Change for Existing Post-Surgical Prostate Cancer Recurrence Test 3/5/2010 8:16:22 AM
Aureon Laboratories Announces Appointment of New Executive Vice President and CFO 1/14/2010 9:19:10 AM
Aureon Laboratories Announces Hiring of Vice President of Sales 10/13/2009 8:17:20 AM
Aureon Laboratories Announces Appointment of New CEO 8/25/2009 8:52:29 AM
M. D. Anderson Cancer Center and Aureon Laboratories to Evaluate Biomarkers Associated with Non-Small Cell Lung Cancer 6/10/2008 8:45:53 AM
Aureon Laboratories Introduces Prostate Px(R)+, First Biopsy-Based Test to Predict Prostate Cancer Disease Progression and Recurrence 5/19/2008 8:54:12 AM
Aureon Laboratories to Collaborate with Pfizer Inc. (PFE) to Establish Quantitative Biometrics for Assessing Therapeutic Response of Prostate Cancer Patients Treated with Hormone Therapy 1/22/2008 9:17:34 AM
Aureon Laboratories to Collaborate with University of California, San Francisco (UCSF) on Research Study to Construct Predictive Models for GM-CSF Treatment Response in Patients with Prostate Cancer 10/15/2007 11:31:50 AM